Dragon Pharmaceutical Inc. Announces 2002 Fourth Quarter and Full Year Results

Dragon Pharmaceutical Inc. (TSX: DDD; OTC BB: DRUG) today announced results for the three-month and twelve-month periods ending December 31, 2002. 2002 Highlights * Generated revenues of $7.36 million, representing significant growth from $3.07 million in 2001. *Enhancement of gross margin in 2002 to 86.7% from 81% in 2001. * Reported a first ever operating […]

Continue reading


Dragon Pharmaceutical Addresses that Its Stock Is Traded on the Berlin-Bremen Stock Exchange

Dragon Pharmaceutical Inc. (TSX: DDD, OTC BB: DRUG) announced today that it has learned that Dragon’s stock has been traded on the Berlin-Bremen Stock Exchange without any prior knowledge from the Company. Based on the press releases from many other companies on the Over-the-counter Bulletin Board, we believe that many companies have encountered the same […]

Continue reading